55132 Federal Register / Vol. 70, No. 181 / Tuesday, September 20, 2005 / Notices 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than October 4, 2005. 

A. Federal Reserve Bank of Cleveland 

(Cindy West, Manager) 1455 East Sixth 

Street, Cleveland, Ohio 44101-2566: 

1. The PNC Financial Services Group, 

Inc., Pittsburgh, Pennsylvania; to 

acquire HW Holdings, Richmond, 

Virginia, and thereby indirectly acquire 

Harris Williams & Co., and Harris 

Williams Advisors, Inc., and engage in 

broker dealer activities and advising 

clients on merger and acquisition 

matters, pursuant to sections 

225.28(b)(6)(iii) and (b)(7)(i) of 

Regulation Y. 

Board of Governors of the Federal Reserve 

System, September 15, 2005. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 05–18695 Filed 9–19–05; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Childhood 

Lead Poisoning Prevention (ACCLPP): 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the National Center for 

Environmental Health (NCEH) of the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following committee meeting. 

Name: Advisory Committee on Childhood 

Lead Poisoning Prevention. 

Times and Dates: 8:30 a.m.–5:45 p.m., 

October 25, 2005. 8:30 a.m.–12:45 p.m., 

October 26, 2005. 

Place: The Hubert Humphrey Federal 

Building, 200 Independence Avenue, SW., 

Washington, DC 20201. Telephone: (202) 

619–0100. 

Status: Open to the public, limited only by 

the space available. Non-federal attendees 

must call Crystal Gresham prior to October 

24, 2005, in order to be received as a visitor 

at the Humphrey building on the day of the 

meeting. The meeting room accommodates 

approximately 60 people. 

Purpose: The Committee provides advice 

and guidance to the Secretary; the Assistant 

Secretary for Health; and the Director, CDC, 

regarding new scientific knowledge and 

technological developments and their 

practical implications for childhood lead 

poisoning prevention efforts. The Committee 

also reviews and reports regularly on 

childhood lead poisoning prevention 

practices and recommend improvements in 

national childhood lead poisoning 

prevention efforts. 

Matters To Be Discussed: Agenda items 

includes: Primary Prevention Workgroup 

update; Forum on strategies for 

implementation of housing-based Primary 

Prevention of Lead Poisoning-federal agency 

perspective; Forum-local agencies and nongovernmental organization perspective; 

Washington, DC Childhood Lead Poisoning 

Prevention Program; Update on the Centers 

for Medicare and Medicaid Services and CDC 

Policy on Targeted Screening of Medicaid 

Children; update on adverse health effects of 

blood lead levels <10 mg/dl—follow-up; and 

update on clinical papers. 

Agenda items are subject to change as 

priorities dictate. 

Opportunities will be provided during the 

meeting for oral comments. Depending on the 

time available and the number of requests, it 

may be necessary to limit the time of each 

presenter. 

Contact Person for More Information: 

Crystal M. Gresham, Management and 

Program Analyst, Lead Poisoning Prevention 

Branch, Division of Emergency and 

Environmental Health Services, NCEH, CDC, 

4770 Buford Hwy, NE., M/S F–40, Atlanta, 

Georgia 30341. Telephone: (770) 488–7490, 

fax: (770) 488–3635. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 12, 2005. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 05–18690 Filed 9–19–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

CDC/HRSA Advisory Committee on 

HIV and STD Prevention and Treatment 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting. 

Name: CDC/HRSA Advisory Committee on 

HIV and STD Prevention and Treatment. 

Time and Date: 8 a.m.–5 p.m., October 19, 

2005. 

Place: Hotel Washington, 15th and 

Pennsylvania Avenue, NW., Washington, DC 

20004. Telephone: (202) 638–5900. 

Time and Date: 8 a.m.–12 p.m., October 20, 

2005. 

Place: Ronald Reagan Building and 

International Trade Center, Horizon Room, 

1300 Pennsylvania Avenue, NW., 

Washington, DC 20004. Telephone: (202) 

213–1300. 

Status: Open to the public, limited only by 

the space available. The meeting room will 

accommodate approximately 100 people. 

Purpose: This Committee is charged with 

advising the Secretary; the Director, CDC; 

and the Administrator, HRSA, regarding 

activities related to prevention and control of 

HIV/AIDS and other STDs, the support of 

health care services to persons living with 

HIV/AIDS, and education of health 

professionals and the public about HIV/AIDS 

and other STDs. 

Matters To Be Discussed: Agenda items 

include issues pertaining to (1) syphilis 

elimination, (2) HIV Prevention Priorities for 

African American Men Who Have Sex With 

Men, (3) Medicare Part D Outreach/TA, and 

(4) Ryan White CARE Act Reauthorization. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Paulette Ford-Knights, Public Health Analyst, 

National Center for HIV, STD, and TB 

Prevention, 1600 Clifton Road, NE., Mailstop 

E–07, Atlanta, Georgia 30333. Telephone 

(404) 639–8008, fax: (404) 639–3125, e-mail 

pbf7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 12, 2005. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 05–18687 Filed 9–19–05; 8:45 am] 

BILLING CODE 4163–18–P